International Journal of Nephrology and Renovascular Disease (Dec 2021)

Effect of Citrate-Acidified Dialysate on Intact Parathyroid Hormone in Prevalent Hemodialysis Patients: A Matched Retrospective Cohort Study

  • Ficociello LH,
  • Zhou M,
  • Mullon C,
  • Anger MS,
  • Kossmann RJ

Journal volume & issue
Vol. Volume 14
pp. 475 – 486

Abstract

Read online

Linda H Ficociello,1 Meijiao Zhou,1 Claudy Mullon,1,2 Michael S Anger,1,2 Robert J Kossmann1 1Fresenius Medical Care, Global Medical Office, Waltham, MA, USA; 2Fresenius Medical Care, Renal Therapies Group, Waltham, MA, USACorrespondence: Robert J Kossmann Email [email protected]: It has been proposed that substituting citrate-acidified dialysate (CAD) solutions for acetate-acidified dialysate (AAD) could improve hemodynamics and dialysis tolerance and reduce the requirement for systemic anticoagulation. Citrate chelates ionized calcium, but long-term effects of CAD use during maintenance hemodialysis have not been well studied. While many studies of the effects of CAD on serum calcium and intact parathyroid hormone (iPTH) have been short-term or have been limited by sample size, we aimed to determine if there are any long-term (i.e., 6-month) changes from pre-dialysis iPTH levels when patients are switched from AAD to CAD.Methods: This retrospective cohort study compared various clinical parameters, including pre-dialysis iPTH and serum calcium as well as single pool Kt/V, from eligible patients who received in-center hemodialysis thrice-weekly in geographically matched CAD (n=3) or AAD clinics (n=12). CAD clinics were defined as clinics converting from AAD to CAD if > 85% of the patients were prescribed CAD after implementation of CAD within the clinic.Results: Pre-dialysis iPTH was not significantly different from baseline to 6-month follow-up within either CAD or AAD clinics. Moreover, the mean change from baseline to month 6 in iPTH between patients (n=142) in CAD clinics (− 17 pg/mL) and patients (n=671) in AAD clinics (13 pg/mL) was similar (p = 0.24). Likewise, the differences in the mean change in serum calcium concentrations and dialysis adequacy (single pool Kt/V) were not significant between CAD and AAD clinics. For subgroups of patients who were never prescribed cinacalcet or calcium-based phosphate binders, there were no significantly different categorical shifts in iPTH between CAD and AAD clinics.Conclusion: Similar trends in single pool Kt/V, iPTH, and serum calcium levels were observed in clinics that switched from AAD to CAD versus the geographically matched AAD clinics. These results support CAD as a potential alternative to AAD in hemodialysis.Keywords: hemodialysis, citrate-acidified dialysate, acetate-acidified dialysate, parathyroid hormone, iPTH, serum calcium

Keywords